# Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)

> **NCT05246813** · — · RECRUITING · sponsor: **Imelda Hospital, Bonheiden** · enrollment: 24 (estimated)

## Conditions studied

- Osteoporosis
- Osteoarthritis, Hip
- Hip Fractures
- Clonal Hematopoiesis of Indeterminate Potential
- Aging

## Interventions

- **OTHER:** Blood and bone marrow cell collection

## Key facts

- **NCT ID:** NCT05246813
- **Lead sponsor:** Imelda Hospital, Bonheiden
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-11
- **Primary completion:** 2028-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05246813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05246813, "Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05246813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*